Over the past 60 years, significant advancements have been made in the manufacturing and clinical use of pacemakers. The Micra TPS is delivered percutaneously, and does not require the use of leads for implant. The success rates of implant are close to 99% in global trials, and they have also shown 48% lesser complications than traditional pacemakers, when it comes to cardiac pacemaker insertion.

Related Portfolio Items